medical decision support medical decision support
Sign In

BARD Score for Fibrosis in Nonalcoholic Fatty Liver Disease (NAFLD)

Purpose: To evaluate a patient with nonalcoholic fatty liver disease (NAFLD) using the BARD score of Harrison et al.

Description

Harrison et al reported the BARD score for the evaluation of patients with nonalcoholic fatty liver diseaes (NAFLD). It can help to identify patients with advanced liver fibrosis. The authors are from Brooke Army Medical Center in San Antonio and Saint Louis University.


Patient selection: NAFLD

 

Outcome: significant hepatic fibrosis

 

BARD is an acronym for:

(1) BMI (B)

(2) AST to ALT ratio (AR)

(3) type 2 diabetes (T)

 

Parameter

Finding

Points

body mass index

< 28 kg per square m

0

 

>= 28

1

AST/ALT ratio

< 0.8

0

 

>= 0.8

2

type 2 diabetes

absent

0

 

present

1

 

total score =

= SUM(points for all 3 parameters)

 

Interpretation:

• minimum score: 0

• maximum score: 4

• A score >= 2 was associated with significant hepatic fibrosis (Stage 3 or 4).

 

Performance:

• The negative predictive value was 0.96.

• The area under the ROC curve was 0.81.


To read more or access our algorithms and calculators, please log in or register.

Specialty

Objective

ICD-10